메뉴 건너뛰기




Volumn 349, Issue 24, 2003, Pages 2334-2339

Use of an Anti-Interleukin-5 Antibody in the Hypereosinophilic Syndrome with Eosinophilic Dermatitis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID; DAPSONE; HUMANIZED INTERLEUKIN 5 ANTIBODY; IMATINIB; INTERLEUKIN 5 ANTIBODY; MEPOZULIMAB; PREDNISOLONE; UNCLASSIFIED DRUG;

EID: 0346816643     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa031261     Document Type: Article
Times cited : (251)

References (16)
  • 1
    • 0016430025 scopus 로고
    • The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature
    • Chusid MJ, Dale CD, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975;54:1-27.
    • (1975) Medicine (Baltimore) , vol.54 , pp. 1-27
    • Chusid, M.J.1    Dale, C.D.2    West, B.C.3    Wolff, S.M.4
  • 2
    • 0028323393 scopus 로고
    • The idiopathic hypereosinophilic syndrome
    • Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994;83:2759-79.
    • (1994) Blood , vol.83 , pp. 2759-2779
    • Weller, P.F.1    Bubley, G.J.2
  • 4
    • 0038386031 scopus 로고    scopus 로고
    • Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders
    • Pardanani A, Reeder T, Porrata LF, et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 2003;101:3391-7.
    • (2003) Blood , vol.101 , pp. 3391-3397
    • Pardanani, A.1    Reeder, T.2    Porrata, L.F.3
  • 5
    • 0344987881 scopus 로고    scopus 로고
    • A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome
    • Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003;348:1201-14.
    • (2003) N Engl J Med , vol.348 , pp. 1201-1214
    • Cools, J.1    DeAngelo, D.J.2    Gotlib, J.3
  • 6
    • 0027958133 scopus 로고
    • Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome
    • Cogan E, Schandené L, Crusiaux A, Cochaux P, Velu T, Goldman M. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994;330:535-8.
    • (1994) N Engl J Med , vol.330 , pp. 535-538
    • Cogan, E.1    Schandené, L.2    Crusiaux, A.3    Cochaux, P.4    Velu, T.5    Goldman, M.6
  • 7
    • 0344809973 scopus 로고    scopus 로고
    • Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia
    • Simon HU, Plötz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999;341:1112-20.
    • (1999) N Engl J Med , vol.341 , pp. 1112-1120
    • Simon, H.U.1    Plötz, S.G.2    Dummer, R.3    Blaser, K.4
  • 8
    • 0036738332 scopus 로고    scopus 로고
    • High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome
    • de Lavareille A, Roufosse F, Schmid-Grendelmeier P, et al. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome. J Allergy Clin Immunol 2002;110:476-9.
    • (2002) J Allergy Clin Immunol , vol.110 , pp. 476-479
    • De Lavareille, A.1    Roufosse, F.2    Schmid-Grendelmeier, P.3
  • 9
    • 0035044957 scopus 로고    scopus 로고
    • Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia
    • Simon HU, Plötz SG, Simon D, Dummer R, Blaser K. Clinical and immunological features of patients with interleukin-5-producing T cell clones and eosinophilia. Int Arch Allergy Immunol 2001;124:242-5.
    • (2001) Int Arch Allergy Immunol , vol.124 , pp. 242-245
    • Simon, H.U.1    Plötz, S.G.2    Simon, D.3    Dummer, R.4    Blaser, K.5
  • 10
    • 6644229440 scopus 로고    scopus 로고
    • Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response
    • Leckie MJ, ten Brinke A, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyperresponsiveness, and the late asthmatic response. Lancet 2000;356:2144-8.
    • (2000) Lancet , vol.356 , pp. 2144-2148
    • Leckie, M.J.1    Ten Brinke, A.2    Khan, J.3
  • 11
    • 0037438409 scopus 로고    scopus 로고
    • Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway
    • Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167:199-204.
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 199-204
    • Flood-Page, P.T.1    Menzies-Gow, A.N.2    Kay, A.B.3    Robinson, D.S.4
  • 13
    • 0031711495 scopus 로고    scopus 로고
    • Skin manifestations in hypereosinophilic syndrome. (HES) - Symptoms, therapy and pathophysiology
    • Plötz SG, Simon HU, Ring J. Skin manifestations in hypereosinophilic syndrome. (HES) - symptoms, therapy and pathophysiology. Allergologie 1999;21:489-96.
    • (1999) Allergologie , vol.21 , pp. 489-496
    • Plötz, S.G.1    Simon, H.U.2    Ring, J.3
  • 15
    • 0031569468 scopus 로고    scopus 로고
    • Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
    • Simon HU, Yousefi S, Schranz C, Schapowal A, Bachert C, Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
    • (1997) J Immunol , vol.158 , pp. 3902-3908
    • Simon, H.U.1    Yousefi, S.2    Schranz, C.3    Schapowal, A.4    Bachert, C.5    Blaser, K.6
  • 16
    • 0037013925 scopus 로고    scopus 로고
    • Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airway hyperreactivity in experimental asthma
    • Martes J, Yang M, Mahalingam S, et al. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airway hyperreactivity in experimental asthma. J Exp Med 2002;195:1433-44.
    • (2002) J Exp Med , vol.195 , pp. 1433-1444
    • Martes, J.1    Yang, M.2    Mahalingam, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.